Skip to main content
    N

    Neogen Corporation (NEOG)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $10.88
    -0.35 (-3.12%)

    Market Cap: $2.45B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Neogen Corporation (NEOG) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Neogen (NEOG) trades at 32.0x trailing earnings and 2.7x sales. Its P/E of 32.0x is below its 5-year median of 33.8x. Its forward P/E is 16.0x. The median P/E across 8 similar companies is 22.6x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 100.0% higher over the next year. Its free cash flow yield is 2.1%.

    MultipleValue
    P/E (trailing)32.0x
    Forward P/E16.0x
    Price to sales2.7x
    Price to book1.1x
    EV/EBITDA26.2x
    Price to FCF47.7x
    EV/FCF59.8x
    PEG0.7
    FCF yield2.1%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 37.5% below 51.2x, its P/S is 62.5% below 7.2x and its P/B is 76.1% below 4.6x.

    MultipleCurrent5-year median10-year median
    P/E32.0x33.8x51.2x
    P/S2.7x3.5x7.2x
    P/B1.1x1.2x4.6x
    Medians of month-end values through Oct 2026: 58 to 60 months (5-year) and 118 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 24.1x in 2025 to 87.5x in 2017. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$6.9924.1x1.7x0.7x
    2024$12.1430.4x2.9x1.0x
    2023$20.1141.9x4.8x1.4x
    2022$15.2326.7x3.2x1.1x
    2021$45.4184.1x9.7x5.6x
    2020$39.6568.4x9.7x5.4x
    2019$32.6356.3x8.2x5.0x
    2018$28.5047.5x7.3x4.9x
    2017$41.1187.5x9.6x8.1x
    2016$33.0084.6x7.8x5.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NEOG

    What is NEOG's forward P/E ratio?

    Neogen has a forward P/E ratio of 16.0x.

    Is NEOG stock overvalued?

    GNG's valuation label for NEOG is Undervalued. Its P/E of 32.0x compares with a median of 22.6x across 8 similar companies.

    What is NEOG's price to sales ratio?

    Neogen has a price to sales ratio of 2.7x.

    What is Neogen's average P/E ratio over 5 years?

    Neogen's median P/E over the last 5 years is 33.8x, from 60 month-end values through Oct 2026.

    What is NEOG's PEG ratio?

    Neogen has a PEG ratio of 0.7.